Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Pathogen-specific T cell depletion and reactivation of opportunistic pathogens in HIV infection.

Geldmacher C, Koup RA.

Trends Immunol. 2012 May;33(5):207-14. doi: 10.1016/j.it.2012.01.011.

2.

[Deep lung--cellular reaction to HIV].

Tavares Marques MA, Alves V, Duque V, Botelho MF.

Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Review. Portuguese.

PMID:
17492233
3.

T cell susceptibility to HIV influences outcome of opportunistic infections.

Saharia KK, Koup RA.

Cell. 2013 Oct 24;155(3):505-14. doi: 10.1016/j.cell.2013.09.045.

4.

Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions.

Porichis F, Hart MG, Zupkosky J, Barblu L, Kwon DS, McMullen A, Brennan T, Ahmed R, Freeman GJ, Kavanagh DG, Kaufmann DE.

J Virol. 2014 Mar;88(5):2508-18. doi: 10.1128/JVI.02034-13.

5.

Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection.

Geldmacher C, Ngwenyama N, Schuetz A, Petrovas C, Reither K, Heeregrave EJ, Casazza JP, Ambrozak DR, Louder M, Ampofo W, Pollakis G, Hill B, Sanga E, Saathoff E, Maboko L, Roederer M, Paxton WA, Hoelscher M, Koup RA.

J Exp Med. 2010 Dec 20;207(13):2869-81. doi: 10.1084/jem.20100090.

6.

Induction of specific T-cell responses in HIV infection.

Leandersson AC, Bratt G, Hinkula J, Gilljam G, Cochaux P, Samson M, Sandström E, Wahren B.

AIDS. 1998 Jan 22;12(2):157-66.

PMID:
9468364
7.

Distinct gene-expression profiles associated with the susceptibility of pathogen-specific CD4 T cells to HIV-1 infection.

Hu H, Nau M, Ehrenberg P, Chenine AL, Macedo C, Zhou Y, Daye ZJ, Wei Z, Vahey M, Michael NL, Kim JH, Marovich M, Ratto-Kim S.

Blood. 2013 Feb 14;121(7):1136-44. doi: 10.1182/blood-2012-07-446278.

8.

Analysis of the antigen specific T cell repertoires in HIV infection.

Li Pira G, Bottone L, Fenoglio D, Terranova P, Pontali E, Ivaldi F, Del Galdo F, Mortara L, Loregian A, Palù G, Kunkl A, Accolla R, De Palma R, Manca F.

Immunol Lett. 2001 Nov 1;79(1-2):85-91.

PMID:
11595293
9.

The majority of CD4+ T-cell depletion during acute simian-human immunodeficiency virus SHIV89.6P infection occurs in uninfected cells.

Matrajt L, Younan PM, Kiem HP, Schiffer JT.

J Virol. 2014 Mar;88(6):3202-12. doi: 10.1128/JVI.03428-13.

11.
12.

The value of preserving HIV-specific immune responses.

Kaufmann DE, Rosenberg ES.

J HIV Ther. 2003 Feb;8(1):19-25. Review.

PMID:
12840711
13.

Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.

Nehete PN, Chitta S, Hossain MM, Hill L, Bernacky BJ, Baze W, Arlinghaus RB, Sastry KJ.

Vaccine. 2001 Dec 12;20(5-6):813-25.

PMID:
11738745
15.

Impaired T-cell priming and proliferation in cats infected with feline immunodeficiency virus.

Bishop SA, Williams NA, Gruffydd-Jones TJ, Harbour DA, Stokes CR.

AIDS. 1992 Mar;6(3):287-93.

PMID:
1348945
16.

Mechanisms of immune activation of human immunodeficiency virus in monocytes/macrophages.

Schrier RD, McCutchan JA, Wiley CA.

J Virol. 1993 Oct;67(10):5713-20.

17.

Disrupting T-cell homeostasis: how HIV-1 infection causes disease.

Douek DC.

AIDS Rev. 2003 Jul-Sep;5(3):172-7. Review.

PMID:
14598566
18.

Innate immune system damage in human immunodeficiency virus type 1 infection. Implications for acquired immunity and vaccine design.

Howie S, Ramage R, Hewson T.

Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 2):S141-5.

PMID:
11029383
19.

Vaccine-induced CD107a+ CD4+ T cells are resistant to depletion following AIDS virus infection.

Terahara K, Ishii H, Nomura T, Takahashi N, Takeda A, Shiino T, Tsunetsugu-Yokota Y, Matano T.

J Virol. 2014 Dec;88(24):14232-40. doi: 10.1128/JVI.02032-14.

20.

Immunisation with gp160 in HIV-1 infection.

Fiala C, Stewart GT.

Lancet. 1999 Sep 11;354(9182):948; author reply 949. No abstract available.

PMID:
10489976
Items per page

Supplemental Content

Support Center